Pharmaceuticals

Latest KFF Health News Stories

VPH: nueva versión de la vacuna previene el contagio con solo dos dosis

KFF Health News Original

Defensores de la salud pública esperan que con la nueva recomendación de administrar solo dos dosis de la vacuna contra el VPH a niñas y niños de entre 9 y 14 años las tasas de vacunación mejoren.

Nueva droga baja el colesterol en forma drámatica y previene ataques, pero es costosísima

KFF Health News Original

Por primera vez, una investigación muestra que un nuevo, y costoso, medicamento llamado Repatha no sólo baja dramáticamente los niveles de colesterol malo (LDL) sino que también reduce el riesgo de ser hospitalizado y de morir.

By The Numbers: Trump’s Choice For FDA Chief Is Versatile, Entrenched In Pharma

KFF Health News Original

The numbers show that President Trump’s choice for FDA commissioner, Scott Gottlieb, has long-standing ties to pharmaceutical companies as a board member or consultant and that he had to recuse himself multiple times while working at the FDA.

HMO Doctors Take Pains To Slash Opioid Prescriptions

KFF Health News Original

A Kaiser Permanente pain management program in Southern California aims to help patients taper off addictive painkillers. Some doctors and patients see it as a godsend; others complain that patients have been cut off medications they need.

Trump, Dems Look For Common Ground On Drug Prices

KFF Health News Original

Two Democratic congressmen met with President Trump to seek his support for a bill to expand the government’s ability to negotiate drug prices, but it’s not clear it would have much impact or will gain support.

‘Right-To-Try’ Laws Expose Dying Patients To Exploitation, Ethicists Warn

KFF Health News Original

More than 30 states have laws on the books to allow dying patients the right to try experimental treatments. But these treatments may not be covered by insurance, and ethicists worry vulnerable people could be exploited near the end of their lives. The laws may also duplicate a process the FDA already has in place.

Instead Of Trashing A $600 EpiPen, Some Patients Get A Refill

KFF Health News Original

Epinephrine, the active ingredient in EpiPens, expires after 18 months, and the auto-injector device can’t be refilled or reused. Health professionals are looking for work-arounds they say could save the health system millions.